Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-16

Clinical Trial Update: Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated combining chemotherapy with warfarin for patients with prostate cancer and thromboembolism; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chemotherapy (unspecified)
  • Warfarin (warfarin)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Prostate Cancer, Thromboembolism | Phase 2 | Status: COMPLETED